Glioblastoma multiforme (GBM) is highly resistant to current anticancer treatments, which
makes it crucial to find new therapeutic strategies aimed at improving the poor prognosis of …

Glioblastoma multiforme (GBM) is the most frequent and aggressive form of brain cancer.
These features are explained at least in part by the high resistance exhibited by these …

Glioblastoma multiforme (GBM) is the most frequent and aggressive type of brain tumor due,
at least in part, to its poor response to current anticancer treatments. These features could be …

Glioblastoma (GBM) is the most malignant brain tumor and one of the deadliest types of
solid cancer overall. Despite aggressive therapeutic approaches consisting of maximum …

High-grade glioma is one of the most aggressive cancers in adult humans and long-term
survival rates are very low as standard treatments for glioma remain largely unsuccessful …

Simple Summary Glioblastomas (GBMs) are aggressive brain tumors with frequent genetic
defects in TP53 and PTEN tumor suppressor genes, which render tumors refractory to …

Cannabinoids, the active components of Cannabis sativa L., act in the body by mimicking
endogenous substances—the endocannabinoids—that activate specific cell surface …

Normal tissue toxicity limits the efficacy of current treatment modalities for glioblastoma
multiforme (GBM). We evaluated the influence of cannabinoids on cell proliferation, death …

Evidence suggests that the nonpsychotropic cannabis-derived compound, cannabidiol
(CBD), has antineoplastic activity in multiple types of cancers, including glioblastoma …

Recently, cannabinoids (CBs) have been shown to possess antitumor properties. Because
the psychoactivity of cannabinoid compounds limits their medicinal usage, we undertook the …